Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics

ANI Pharmaceuticals (ANIP) reported $138.04 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 18.4$1.02 for the same period compares to $1.28 a year ago.The reported revenue represents a surprise of +8.16$127.62 million. With the consensus EPS estimate being $0.93, the EPS surprise was +9.68%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to W ...